Bharat Immunologicals & Biologicals Corporation Ltd.

  • Value Research Rating market-capitalisation-info
    UnratedSee Why?
  • Market Capitalisation market-capitalisation-info ₹131 Cr
  • Price to Earnings Ratio price-to-earning --
  • 12 Month Earnings monthly-earning ₹-17 Cr

Bharat Immunologicals & Biologicals Corporation Ltd. Share Price

₹29.80

As on 14-Aug-2024 10:28 IST

up-down-arrow-0.53-1.75%

  • Prev Close info

    30.33

  • Day's Openinfo

    30.30

  • Today's Highinfo

    30.79

  • Today's Lowinfo

    29.30

  • Today's Volumeinfo

    39,471

  • 52 Week rangeinfo

    ₹22.05 - 43.89

Please wait...

Stock Range

Today’s Range
Low 29.30 High: 30.79
52 Week Range
Low 22.05 High: 43.89
Liquidity
Low High

Bharat Immunologicals & Biologicals Corporation Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Bharat Immuno
-15.70 3.11 -0.83 25.90 -16.83 35.39 -2.52
BSE Healthcare
29.84 6.68 16.72 46.55 16.54 26.64 12.71
BSE Small Cap
23.89 -2.12 16.73 49.81 26.12 33.39 18.47
As on 14-Aug-2024
2023
2022
2021
2020
2019
2018
2017
Bharat Immuno
-11.40 -31.74 11.97 598.76 -38.50 -65.77 67.64
BSE Small Cap
47.52 -1.80 62.77 32.11 -6.85 -23.41 59.64
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Essential Checks

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Bharat Immunologicals & Biologicals Corporation Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Bharat Immunologicals & Biologicals Corporation Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Bharat Immunologicals & Biologicals Corporation Ltd.

        No Review & Analysis are available.

        Other details of Bharat Immunologicals & Biologicals Corporation Ltd.

        Incorporated

        1989

        Chairman

        Sudhanshu Vrati

        Managing Director

        Dhananjay Kumar Tiwary

        Group

        PSU

        Headquarters

        Bulandshahar, Uttar Pradesh

        FAQs for Bharat Immunologicals & Biologicals Corporation Ltd.

        The total asset value of Bharat Immunologicals & Biologicals Corporation Ltd stood at ₹ 189 Cr as on 31-Mar-23

        The share price of Bharat Immunologicals & Biologicals Corporation Ltd is ₹29.80 (BSE) as of 14-Aug-2024 10:28 IST. Bharat Immunologicals & Biologicals Corporation Ltd has given a return of -16.83% in the last 3 years.

        Bharat Immunologicals & Biologicals Corporation Ltd has a market capitalisation of ₹ 131 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Bharat Immunologicals & Biologicals Corporation Ltd is -4.03 times as on 13-Aug-2024, a 645% discount to its peers’ median range of 0.74 times.

        Since, TTM earnings of Bharat Immunologicals & Biologicals Corporation Ltd is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Bharat Immunologicals & Biologicals Corporation Ltd and enter the required number of quantities and click on buy to purchase the shares of Bharat Immunologicals & Biologicals Corporation Ltd.

        Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, ready to use therapeutic food, low calorie sweetener tablets, etc. The company was founded in 1989 and is based in Bulandshahr, India.

        The promoter of Bharat Immunologicals & Biologicals Corporation Ltd is PRESIDENT OF INDIA. PRESIDENT OF INDIA owns 59.25 per cent of the total equity. The chairman of the company is Sudhanshu Vrati , and the managing director is Dhananjay Kumar Tiwary..

        There is no promoter pledging in Bharat Immunologicals & Biologicals Corporation Ltd.

        Bharat Immunologicals & Biologicals Corporation Ltd. Ratios
        Return on equity(%)
        0
        Operating margin(%)
        -36.47
        Net Margin(%)
        -36.43
        Dividend yield(%)
        0

        No, TTM profit after tax of Bharat Immunologicals & Biologicals Corporation Ltd was ₹-17 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Review & Analysis

        No Review & Analysis are available.

        Key Facts

        • Market cap market-cap-information ₹130.96 Cr
        • Revenue (TTM)revenue-information ₹44.61 Cr
        • Earnings (TTM) earning-information ₹-16.64 Cr
        • Cash date-information ₹8.74 Cr
        • Total Debt info ₹70.22 Cr
        • Promoters' ownership promoters_ownership 59.25%
        • Liquidity liquidity High
        • 52 Week range week-range ₹22.05 - 43.89
        • Face value face-value ₹10.00
        • Shares outstanding share-outstanding 4,31,80,000
        • 10 Years Aggregate:

          CFO: ₹-45.36 Cr

          EBITDA: ₹-45.38 Cr

          Net Profit: ₹-55.52 Cr

        About The Company

        • Incorporated 1989
        • Chairman Sudhanshu Vrati
        • Managing Director Dhananjay Kumar Tiwary
        • Group PSU
        • Listing key-listing BSE: 524663
        • Country India
        • Headquarters headquarters Bulandshahar, Uttar Pradesh
        • Website website www.bibcol.com
        • Business

          Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, ready to use therapeutic...  food, low calorie sweetener tablets, etc. The company was founded in 1989 and is based in Bulandshahr, India.  Read more